When Curnis et al. (2000) fused the NH2 terminus of TNF with the COOH terminus of peptides containing the NGR motif, the resulting NGR-hTNF conjugate could specifically bind with CD13, which is required for the development of tumor vessels. Here, TNF is linked to neoplasm.